Disclosures for "Evobrutinib therapeutic response is associated with an increase in the number and maturation of peripheral and central classical dendritic cells")
-
The institution of Dr. Clemente has received research support from EMD Serono Research & Development Institute, Inc.. The institution of Dr. Clemente has received research support from Bristol Myers Squibb. The institution of Dr. Clemente has received research support from Instituto de Salud Carlos III. Dr. Clemente has received personal compensation in the range of $500-$4,999 for serving as a Reviewer of Grants with Spanish National Investigation Agency.
-
Dr. Serrano Regal has nothing to disclose.
-
Dr. Calahorra has nothing to disclose.
-
Miss Alonso García has nothing to disclose.
-
Ursula Boschert has nothing to disclose.
-
Philipp Haselmayer has received personal compensation for serving as an employee of Merck Healthcare KGaA.
-
Dr. Ortega has nothing to disclose.
-
Miss Díaz has nothing to disclose.
-
Mrs. Camacho Toledano has nothing to disclose.
-
Mrs. Arocha has nothing to disclose.